Sonorous Neurovascular Advances Care with BosCATH Approval
Lake Forest, California, USA – April 22, 2026 In a significant advancement for neurovascular intervention technology, Sonorous Neurovascular has...
AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development EMA FDA fda approval FDA clearance Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Lake Forest, California, USA – April 22, 2026 In a significant advancement for neurovascular intervention technology, Sonorous Neurovascular has...
